Site Search
Search Results
Tina Tankka: Lafayette, CA
... of which are directly taken from multiple myeloma remedies. The swiftness with how my husband's treatments were set in motion, I attribute to biomarker testing that was given early on in his diagnosis - chemo, therapy, immunotherapy, immunotherapy again, and finally, an immunotherapy that is a bispecific T-cell engager. Both biomarker testing and our proximity to state-of-the-art medical research facilities are why he is alive today - 8 years hence. We need everyone ...
Maine 2024 Legislative Priorities
... products. We will be making the following fact-based policies a priority and ask for your support: Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...
2024 Florida Legislative Summary
... Action Network (ACS CAN) worked with the Florida Legislature in support of the following priorities: Ensuring Access to Quality Care Access to Biomarker Testing : ACS CAN supports legislation that improves coverage of comprehensive biomarker testing. During the 2024 Legislative Session, HB 885, related to biomarker testing, passed unanimously. The bill requires the state’s ...
Maine 2025 Legislative Priorities
... will be making the following fact-based policies a priority and ask for your support: Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...
WA 2025 Cancer Action Day Participant Info HUB
... 2024 CAD Participant Packet How to Reserach Your Lawmakers | Power Analysis Homework agenda_wa_cad_24.pdf Learn More About Our Priority, Biomarker Testing Coverage (More Issues & Info TBA) Biomarker Testing FAQ Health Equity in Biomarker Testing Check out our biomarker testing coverage in Washington website here . Washington State ...
Washington 2026 Legislative Priorities
... that create barriers or reduce access to care for cancer patients, survivors, and those who could be diagnosed with cancer. Access to Biomarker Testing – HB 1062: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...
2026 Delaware Cancer Action Day
... (ACS CAN) and the Alzheimer's Association. Join us by sending your lawmakers a message urging them to expand insurance coverage for biomarker testing, so more patients can access the personalized, life-saving treatments they need. 0 2026 Delaware Cancer Action Day ...
State Senator Devlin Robinson Receives National Distinguished Advocacy Award for Leading the Way on Critical Cancer Legislation
... as a leader and true advocate on cancer advocacy issues,” said Lisa Lacasse, president of ACS CAN. “From advocating for the passage of biomarker legislation in Pennsylvania to sponsoring the Pennsylvania Paid Family & Medical Leave Act, Senator Robinson has tirelessly advocated for ... in Pennsylvania are very fortunate to have an ally like Senator Robinson in the Legislature. Through his work aimed at improving access to biomarker testing and paid family and medical leave, he has shown a singular commitment to reducing the cancer burden for Pennsylvanians. As someone who has ...
Hawai’i Cancer Community Urges State Lawmakers to Defend Medicaid and Expand Colon Cancer Screening Access
... for uninsured and underinsured individuals, including the follow-up colonoscopy required after a positive noninvasive screening test. Biomarker Testing: ACS CAN will continue to advocate for improved coverage of comprehensive biomarker testing which is an important step to accessing precision medicine. This includes targeted therapies that can lead to improved ...
2024 West Virginia Legislative Priorities
... for all insurance plans, including traditional Medicaid, to provide a comprehensive benefit for lung cancer screening including all follow-up testing according to recommended guidelines, without enrollee cost sharing or other barriers. Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...
Type
Priority Issue
State
- New York (33) Apply New York filter
- Ohio (17) Apply Ohio filter
- Pennsylvania (17) Apply Pennsylvania filter
- California (15) Apply California filter
- Washington (15) Apply Washington filter
- Maine (13) Apply Maine filter
- New Jersey (13) Apply New Jersey filter
- Hawaii (12) Apply Hawaii filter
- Florida (10) Apply Florida filter
- Colorado (9) Apply Colorado filter
- Connecticut (9) Apply Connecticut filter
- Massachusetts (9) Apply Massachusetts filter
- Tennessee (9) Apply Tennessee filter
- Georgia (8) Apply Georgia filter
- Illinois (8) Apply Illinois filter
- Kentucky (8) Apply Kentucky filter
- Delaware (7) Apply Delaware filter
- Maryland (7) Apply Maryland filter
- National (7) Apply National filter
- New Hampshire (7) Apply New Hampshire filter
- North Carolina (7) Apply North Carolina filter
- Vermont (7) Apply Vermont filter
- Nevada (6) Apply Nevada filter
- Arizona (5) Apply Arizona filter
- Iowa (5) Apply Iowa filter
- Mississippi (5) Apply Mississippi filter
- Texas (5) Apply Texas filter
- West Virginia (5) Apply West Virginia filter
- Indiana (4) Apply Indiana filter
- Minnesota (4) Apply Minnesota filter
- New Mexico (4) Apply New Mexico filter
- Oklahoma (4) Apply Oklahoma filter
- Oregon (4) Apply Oregon filter
- Nebraska (3) Apply Nebraska filter
- Rhode Island (2) Apply Rhode Island filter
- Alaska (1) Apply Alaska filter
- Louisiana (1) Apply Louisiana filter
- Michigan (1) Apply Michigan filter
- South Dakota (1) Apply South Dakota filter